Search Results - "Tun, Yin Nwe"

Preliminary experience with drug-coated balloon angioplasty in primary percutaneous coronary intervention by Ho, Hee Hwa, Tan, Julian, Ooi, Yau Wei, Loh, Kwok Kong, Aung, Than Htike, Yin, Nwe Tun, Sinaga, Dasdo Antonius, Jafary, Fahim Haider, Ong, Paul Jau Lueng

“…We evaluated the clinical feasibility of using drugcoated balloon(DCB) angioplasty in patients undergoingprimary percutaneous coronary intervention(PPCI)…”
Get full text

LBODP108 Did You Follow Your Patient After ICI Cessation? A Case of Immune-Related Adverse Event 5 Months Following Completion Of Immunotherapy by Kedarisetti, Sreekari, Vetrici, Mariana, Tun, Yin Nwe

“…Abstract Introduction Immune checkpoint inhibitors (ICI) have been approved for use in cancer therapy for malignant melanoma, non-small cell lung cancer, and…”
Get full text

SAT-493 A Case of Profound Hypothyroidism Secondary to Immune Check Point Inhibitors by Tun, Yin Nwe, Rodriguez, Giovanna, Bahtiyar, Gul

“…Abstract Background: The discovery of immune check-point inhibitors (ICI) revolutionized cancer treatment. CTLA-4, anti-PD-1 and anti-PD-L1 monoclonal…”
Get full text

A Case of Teriparatide Use in Nonunion Atypical Ulnar Fracture by Tun, Yin Nwe, Russell, Yan, Guber, Helena Abby

“…Abstract Background: Atypical upper limb fracture is a rare complication of bisphosphonate use. The management of nonunion fractures is challenging, especially…”
Get full text

TCTAP A-079 Clinical Efficacy and Safety of Bioresorbable Vascular Scaffold in an Unselected Patient Population: A Single Centre Real World Experience by Ching, Min Er, Ho, Hee Hwa, Ooi, Yau Wei, Beng, Ko, Tan, Julian, Loh, Kwok Kong, Yin, Nwe Tun, Jafary, Fahim Haider, Lueng Ong, Paul Jau

“…The primary endpoint was in-hospital major adverse cardiac events (MACE) ie a composite of cardiovascular death, target vessel related myocardial infarction…”
Get full text